Clinical Trial Update: Glucagon-like Peptide-1 Receptor Agonists for Endovascular Stroke Thrombectomy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is investigating glucagon-like peptide-1 receptor agonists as adjunct therapy for ischemic stroke patients undergoing endovascular thro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Snippet

Sponsor: Population Health Research Institute | Conditions: Ischemic Stroke | Phase 2 | Status: NOT_YET_RECRUITING